Literature DB >> 7247377

Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels.

R Yogev, W E Schultz, S B Rosenman.   

Abstract

Fourteen hydrocephalic pediatric patients with suspected shunt infections were studied for penetrance of nafcillin into the ventricular fluid after intravenous administration. In seven patients with bacterial ventriculitis, the concentration of nafcillin in ventricular fluid was 0.8 to 20.4% of the peak concentration in serum. In the remaining seven patients without bacterial ventriculitis, ventricular fluid levels ranged between less than or equal to 0.02 to 4% of peak serum concentrations. Although the degree of pleocytosis correlated poorly with penetrance, ventricular fluid glucose levels correlated inversely with penetrance of nafcillin (r = -0.7275, P less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247377      PMCID: PMC181474          DOI: 10.1128/AAC.19.4.545

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Methicillin.

Authors:  A H DOUTHWAITE; J A TRAFFORD; D A McGILL; I E EVANS
Journal:  Br Med J       Date:  1961-07-01

2.  Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections.

Authors:  J G Kane; R H Parker; G W Jordan; P D Hoeprich
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

3.  Nafcillin entry into human cerebrospinal fluid.

Authors:  B E Fossieck; J G Kane; C R Diaz; R H Parker
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

4.  Pathogenesis of meningitis. VIII. Cerebrospinal fluid and blood concentrations of methicillin, cephalothin, and cephaloridine in experimental pneumococcal meningitis.

Authors:  S Oppenheimer; H N Beaty; R G Petersdorf
Journal:  J Lab Clin Med       Date:  1969-04

5.  Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics.

Authors:  L D Sabath; C Garner; C Wilcox; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

6.  Neurosurgical shunt infections. A review.

Authors:  R Yogev; A T Davis
Journal:  Childs Brain       Date:  1980

7.  Nafcillin treatment of Staphylococcus aureus meningitis.

Authors:  D E Ruiz; J F Warner
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

8.  Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy.

Authors:  S C Schoenbaum; P Gardner; J Shillito
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

9.  Clinical and pharmacokinetic evaluation of nafcillin in infants and children.

Authors:  W E Feldman; J D Nelson; L R Stanberry
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

10.  Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections.

Authors:  L M Kancir; C U Tuazon; T A Cardella; J N Sheagren
Journal:  Arch Intern Med       Date:  1978-06
View more
  3 in total

1.  Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.

Authors:  K Allegaert; I Scheers; E Adams; G Brajanoski; V Cossey; B J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

Review 2.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

3.  Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients.

Authors:  Alison R Novak; Martin Krsak; Tyree H Kiser; Robert T Neumann; Luis Cava Prado; Kyle C Molina; Scott W Mueller
Journal:  Open Forum Infect Dis       Date:  2021-12-25       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.